(1) | Propylhexedrine (except when part of a compound used for nasal decongestion which is authorized to be sold lawfully over the counter without a prescription under the federal food, drug and cosmetic act, so long as it is used only for such purpose) | 8161 |
(2) | Pyrovalerone | 1485 |
(1) | Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (some trade or other names BRV; UCB-34714; Briviact) | 2710 |
(2) | Cenobamate [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate | 2720 |
(3) | Ezogabine N-[2-amino-4(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester | 2779 |
(4) | Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide] | 2746 |
(5) | Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2- yl-benzamide | 2790 |
(6) | Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid] | 2782 |
K.S.A. 65-4113
Revisor's Note:
Section was also amended by L. 2011, ch. 10, § 5, but that version was repealed by L. 2011, ch. 83, § 9.